Earnings Feed
Start Free
Guardant Health, Inc.·4

Jul 2, 6:12 PM ET

Kalia Kumud 4

4 · Guardant Health, Inc. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardant Health (GH) CIO Kalia Kumud Vests RSUs; 3,066 Shares Withheld

What Happened

  • Kalia Kumud, Chief Information Officer of Guardant Health (GH), had multiple restricted stock unit (RSU) installments convert to common shares on July 1, 2026. A total of 6,046 shares were issued upon vesting (four separate RSU conversions). To cover tax withholding, the company retained (withheld) 3,066 shares at an implied value of $170.77 per share, equal to $523,581. The insider received the remaining 2,980 shares net of withholding.
  • These were vesting conversions of RSU awards (no cash purchase: reported exercise/conversion price $0). The withholding is recorded as a "Payment of exercise price or tax liability" (code F), not an open-market sale.

Key Details

  • Transaction date: July 1, 2026. Form 4 filed July 2, 2026 (next business day; appears timely).
  • Vesting/conversions recorded: 1,607; 1,084; 1,994; and 1,361 shares (total 6,046).
  • Tax withholding: 3,066 shares withheld at $170.77/share = $523,581 (footnote F1: shares retained by company to meet tax obligations; amount not in excess of liability).
  • Net shares delivered to insider: 2,980 (6,046 vested − 3,066 withheld).
  • Related awards/vesting schedules: these conversions relate to RSU grants described in footnotes (grants from Nov 7, 2022; Dec 13, 2023; Nov 8, 2024; Mar 12, 2025) that vest over multi-year schedules (see F2, F4, F5, F6).
  • Codes explained: M = exercise/conversion of derivative (RSU conversion); F = tax withholding payment. F3 is not applicable for RSUs per filing.

Context

  • This is a routine vesting and tax-withholding event, not an open-market sale or purchase. Vesting/withholding transactions are standard compensation mechanics and do not necessarily signal the insider’s market view.
  • For retail investors: purchases or open-market buys are typically more informative about insider sentiment; RSU vesting with share withholding is primarily administrative and tax-related.

Insider Transaction Report

Form 4
Period: 2026-07-01
Guardant Health, Inc.GH
Kalia Kumud
Chief Information Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,607→ 42,421 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,084→ 43,505 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,994→ 45,499 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,361→ 46,860 total
  • Tax Payment

    Common Stock

    [F1]
    2026-07-01$170.77/sh−3,066$523,581→ 43,794 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-07-01−1,607→ 1,607 total
    Exercise: $0.00→ Common Stock (1,607 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F4][F3]
    2026-07-01−1,084→ 1,084 total
    Exercise: $0.00→ Common Stock (1,084 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F5][F3]
    2026-07-01−1,994→ 9,973 total
    Exercise: $0.00→ Common Stock (1,994 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F3]
    2026-07-01−1,361→ 9,522 total
    Exercise: $0.00→ Common Stock (1,361 underlying)
Footnotes (6)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F6]This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Signature
/s/ John G. Saia, as attorney-in-fact for Kumud Kalia|2026-07-02

Documents

1 file
  • 4
    wk-form4_1783030330.xmlPrimary

    FORM 4